CLINICAL_TRIALS
trial_result
· 2022-04-15
Clinical Trial Update: Caspase Inhibition in Islet Transplantation [Phase 1, Phase 2]
Summary
The document reports a Phase 1/Phase 2 clinical trial update on caspase inhibition in islet transplantation for diabetes, with the study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Diabetes | Phase 1, Phase 2 | Status: COMPLETED